Quick Answer
Aptose Biosciences Inc. reported Total Assets of $10.01 million for fiscal year 2025.
Aptose Biosciences Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $10.01M | -1.1% |
| 2024 | $10.13M | -22.0% |
| 2023 | $12.99M | -74.5% |
| 2022 | $51.03M | -38.2% |
| 2021 | $82.53M | -34.6% |
| 2020 | $126.26M | +25.7% |
| 2019 | $100.48M | +495.6% |
| 2018 | $16.87M | +41.0% |
| 2017 | $11.97M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.34M | -42.0% | +13.4% |
| June 30, 2025 | $5.59M | -48.9% | -25.1% |
| March 31, 2025 | $7.47M | -41.6% | -26.3% |
| December 31, 2024 | $10.13M | -22.0% | -7.3% |
| September 30, 2024 | $10.93M | -47.6% | -0.2% |
| June 30, 2024 | $10.95M | -58.8% | -14.4% |
| March 31, 2024 | $12.80M | -67.5% | -1.5% |
| December 31, 2023 | $12.99M | -74.5% | -37.8% |
- Aptose Biosciences Inc. showed a decrease of -1.1% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Aptose Biosciences Inc.’s total assets has declined by 16.3% (from $11.97 million to $10.01 million).
- The most recent figure is from Aptose Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: